FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/05/042725 [Registered on: 23/05/2022] Trial Registered Prospectively
Last Modified On: 20/05/2022
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Other (Specify) [Cosmeceuitcal ]  
Study Design  Single Arm Study 
Public Title of Study   Safety & efficacy assessment of products on skin.  
Scientific Title of Study   To evaluate the moisturization effect of two skincare formulations – Cebhydra Cream (WWY0018) & Cebhydra Lotion (WWY0030) on healthy human female subjects 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
XXX-HD01-SN-MH22; Version: 01; Dated: 05/05/2022   Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Raji Patil 
Designation  Investigator 
Affiliation  MASCOT-SPINCONTROL India Pvt. Ltd. 
Address  Kohinnor Estate, 3rd Floor, Sun Mill compound, Lower Parel, Mumbai – 400013, INDIA

Mumbai
MAHARASHTRA
400013
India 
Phone  02243349191  
Fax    
Email  raji@mascotspincontrol.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Raji Patil 
Designation  Investigator 
Affiliation  MASCOT-SPINCONTROL India Pvt. Ltd. 
Address  Kohinnor Estate, 3rd Floor, Sun Mill compound, Lower Parel, Mumbai – 400013, INDIA


MAHARASHTRA
400013
India 
Phone  02243349191  
Fax    
Email  raji@mascotspincontrol.in  
 
Details of Contact Person
Public Query
 
Name  Mr Mohit Lalvani 
Designation  Study Director 
Affiliation  MASCOT-SPINCONTROL India Pvt. Ltd. 
Address  Kohinnor Estate, 3rd Floor, Sun Mill compound, Lower Parel, Mumbai – 400013, INDIA

Mumbai
MAHARASHTRA
400013
India 
Phone  02243349191  
Fax    
Email  mohit@mascotspincontrol.in  
 
Source of Monetary or Material Support  
Mascot Spincontrol India Pvt. Ltd. Kohinnor Estate, 3rd Floor, Sun Mill compound, Lower Parel, Mumbai – 400013, INDIA 
 
Primary Sponsor  
Name  Sun Pharmaceutical Industries Limited 
Address  Sun House, 201 B/1, Western Express Highway, Goregaon (East), Mumbai, Maharashtra (India) – 400 063  
Type of Sponsor  Other [FMCG] 
 
Details of Secondary Sponsor  
Name  Address 
NIL   Not Applicable 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Raji Patil  Mascot Spincontrol India Pvt. Ltd.   Kohinoor Estate, 3rd Floor, Sun Mill Compound, Lower Parel West, Mumbai. Mumbai (Suburban) MAHARASHTRA 400013 India
Mumbai
MAHARASHTRA 
02243349191

raji@mascotspincontrol.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Ethos- An Institutional Ethics committee (Mumbai)   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  having dry skin on inner forearms with corneometer reading of 30 
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Cebhydra Cream (WWY0018)  Application is carried out once at site on the marked areas of 3x3 cm2 on the right inner forearms for the period of 24 hours 
Intervention  Cebhydra Lotion (WWY0030)  Application is carried out once at site on the marked areas of 3x3 cm2 on the right inner forearms for the period of 24 hours 
Comparator Agent  Untreated site  one site of 3x3 cm2 on the right inner forearm is served as untreated control site 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  1. Indian female subjects
2. Healthy subjects (no infectious and evolutive pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory checkup)
3. Between 18 and 40 years of age.
4. Skin is healthy on the studied anatomic unit (e.g., free of eczema, wounds, inflammatory scar).
5. Having dry skin on inner forearms with corneometry reading of <30.
 
 
ExclusionCriteria 
Details  1. For Female: Being pregnant or breastfeeding or having stopped to breastfeed in the past three months.
2. Having started, changed or stopped a hormonal treatment (e.g., hormonal contraception, Hormonal Replacement Therapy, thyroid) in the past 3 months
3. Having taken an oral retinoid-based treatment in the past 6 months.
4. Having had a local retinoid-based treatment on the studied areas in the previous month.
5. Having had beauty treatment (e.g. skin cleansing, exfoliation, scrub, mask) in the previous week
6. Having applied a moisturizing product on the studied areas in the 5 days preceding the start of the study. (only hands cleaned with water is accepted)
7. Having practiced water activities (swimming pool, sauna, hammam, baleneotherapy etc.) in the previous week
8. Having consumed caffeine-based products (coffee, cola, tea), alcohol, highly spiced food and/or not smoke in the two hours preceding the measurements
9. Having practiced intensive sports during the day prior to the T0 measurements
10. Having wounds, Scars, sunburns, tattoos and piercing on test site.
11. Having applied another product than water on the studied areas in the morning of the T0 measurements
12. Having had an intensive UV exposition on the forearms (solariums, sun) during 5 days prior to T0 measurements.
13. Having used any skin care products as well as skin care cleansers such as bath/shower oils on the forearms during 5 days prior to T0 measurements.
14. Having hair on test site.

15. Refusing to follow the restrictions below during the study:
Do not take part in any family planning activities leading to pregnancy and breastfeeding , Do not take part in another study liable to interfere with this study , Do not take medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol), During the study: Do not use other cosmetic products than the tested product to the studied areas., Do not have beauty treatment (e.g. scrub, manicure self-tanning product) , Do not practice water activities (swimming pool, sauna, hammam, balneotherapy etc.), Do not drink/ eat caffeine-based products (coffee, cola, tea), alcohol, highly spiced food, nor smoke , Do not practice sport , Do not apply any product on inner forearms including water., Do not wipe their inner forearms., Do not wear jewels on the wrists, Do not have an intensive UV exposition on the inner forearms (solariums, sun).
 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Percent improvement in capacitance value i.e skin moisturization  30 minutes, 2 hours, 4 hours, 6 hours, 8 hours & 24 hours after product application  
 
Secondary Outcome  
Outcome  TimePoints 
Percent reduction in transepidermal water loss (TEWL), Percent improvement in skin softness , safety of Product  30 minutes, 2 hours, 4 hours, 6 hours, 8 hours & 24 hours after product application  
 
Target Sample Size   Total Sample Size="33"
Sample Size from India="33" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   27/05/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="0"
Days="15" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

The objective of this study is to evaluate the moisturization effect of two skincare formulations – Cebhydra Cream (WWY0018) & Cebhydra Lotion (WWY0030) on healthy human female subjects.

The evaluation is performed using:   

n   Subject Self Evaluation (SSE) Questionnaire (Moisturization Effect & Safety)

n   Subject Self Evaluation (SSE) Questionnaire (Cosmetic Appeal)

n   Dermatological Evaluation : Safety

n   Dermatological Evaluation : Skin softness

n   Corneometry

n   Tewametry


Study Population :

33 female subjects are selected for the stud

The subjects selected for this study are healthy females, aged between 18 and 40 years, having dry skin on inner forearms with corneometer reading of <30.


Study Duration :(Screening period to Last-Patient-Out) (A+B+D): 37 days

Study Duration (First-Patient-In to Last-Patient-Out) (B+D): 23 days

A = Screening period (Period for identification of eligible 33 subjects): 14 days

B = Enrollment period (Period for conducting baseline visits of 33 subjects): 21 days

C = Run-in period: Not applicable

D = Treatment period per patient: 2 days 

 

Study will be carried out on the randomized 3 sites of 3x3 cm2 marked areas on the right inner forearms; product A and product B will be applied at two sites (one test product per site) and one site will serve as untreated control. 

 
Close